Literature DB >> 11034000

Density of Helicobacter pylori infection evaluated semiquantitatively in gastric cancer.

Y Tokunaga1, H Shirahase, T Hoppou, A Kitaoka, A Tokuka, K Ohsumi.   

Abstract

Helicobacter pylori infection may play a role in the development of gastric cancer; however, a quantitative evaluation of the density of H. pylori infection has not been reported previously in relation to the histologic stage and type of cancer. This study was designed to compare the density of H. pylori infection to the histologic stage and type of gastric cancer. Between March 1996 and March 1998, surgical resection of primary lesion was performed in 50 patients with gastric cancer (39 men and 11 women with a mean age of 67 years) at our institution. Using immunohistochemical stains, the density of H. pylori infection was evaluated semiquantitatively at cancer site as well as noncancerous mucosa adjacent to cancer. This density was compared with the histologic stage and the type of gastric cancer. The severity of the mucosal atrophy was evaluated using the updated Sydney System. The prevalences and density of H. pylori infection decreased in proportion to advances in the cancer stage and the mucosal atrophy. In early cancer of the intestinal- and diffuse-type, the prevalence of H. pylori in adjacent sites was almost 90% and was significantly higher (p < 0.01) than that seen in the advanced cancer lesions. In the intestinal-type early cancer, the prevalence and density of infection was higher (p < 0.05) in the adjacent mucosa than in the cancer site, whereas in the diffuse-type early cancer, H. pylori was found in all cases at the cancer site and the adjacent site. In advanced cancer, the prevalence of H. pylori was about 40% in the adjacent site and about 10% in the cancer site in both histologic types. These figures were significantly lower (p < 0.01) than in the early cancers. The prevalence and density of infection did not differ in the intestinal- and diffuse-type gastric cancers, but did decrease with more advanced cancer stages. The changes in local environment of the advanced cancer may not be conducive to the survival of H. pylori. Thus, the prevalence of H. pylori may be affected by the histologic stage rather than the histologic type of gastric cancer, and the organism may play a similar role, but through different pathways, in the pathogenesis of both types of cancer.

Entities:  

Mesh:

Year:  2000        PMID: 11034000     DOI: 10.1097/00004836-200010000-00006

Source DB:  PubMed          Journal:  J Clin Gastroenterol        ISSN: 0192-0790            Impact factor:   3.062


  5 in total

Review 1.  Meta-analysis of the efficacy of probiotics in Helicobacter pylori eradication therapy.

Authors:  Rong Zhu; Kan Chen; Yuan-Yuan Zheng; Hua-Wei Zhang; Jun-Shan Wang; Yu-Jing Xia; Wei-Qi Dai; Fan Wang; Miao Shen; Ping Cheng; Yan Zhang; Cheng-Fen Wang; Jing Yang; Jing-Jing Li; Jie Lu; Ying-Qun Zhou; Chuan-Yong Guo
Journal:  World J Gastroenterol       Date:  2014-12-21       Impact factor: 5.742

2.  Heat shock protein 70 (HSP70) expression is associated with poor prognosis in intestinal type gastric cancer.

Authors:  Hyoun Wook Lee; Eun Hee Lee; Seok-Hyun Kim; Mee Sook Roh; Sang Bong Jung; Young Cheol Choi
Journal:  Virchows Arch       Date:  2013-08-04       Impact factor: 4.064

3.  Fermented milk containing Lactobacillus paracasei and Glycyrrhiza glabra has a beneficial effect in patients with Helicobacter pylori infection: A randomized, double-blind, placebo-controlled study.

Authors:  Jin Young Yoon; Jae Myung Cha; Seong Soo Hong; Hyung Kyung Kim; Min Seob Kwak; Jung Won Jeon; Hyun Phil Shin
Journal:  Medicine (Baltimore)       Date:  2019-08       Impact factor: 1.817

4.  Low SOX12 Expression Is Correlated With Poor Prognosis in Patients With Gastric Cancer.

Authors:  Kan-Kan Yang; Hui-Mian Xu; Jin-Yu Huang; Yu-Xuan Guo; Zhen-Ning Wang
Journal:  Technol Cancer Res Treat       Date:  2020 Jan-Dec

5.  Long-Term Use of Probiotic-Containing Yogurts Is a Safe Way to Prevent Helicobacter pylori: Based on a Mongolian Gerbil's Model.

Authors:  Chao-Hung Kuo; Sophie S W Wang; Chien-Yu Lu; Huang-Ming Hu; Fu-Chen Kuo; Bi-Chuang Weng; Chun-Chieh Wu; Chung-Jung Liu; Pei-Yun Tsai; Tsung-Cheng Lee; Li-Wei Chen; Kuang-Hung Cheng; Lin-Li Chang; Deng-Chyang Wu
Journal:  Biochem Res Int       Date:  2013-11-21
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.